Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines

After worldwide implementation of 10-valent and 13-valent pneumococcal conjugate vaccines (PCV10/PCV13), a 20-valent PCV (PCV20) was developed. We assessed dynamics of non-PCV13 additional PCV20 serotypes (VT20–13), compared with all other non-VT20 serotypes, in children <2 years of age in late P...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Emerg Infect Dis
Hlavní autoři: Ben-Shimol, Shalom, Givon-Lavi, Noga, Kotler, Leore, Adriaan van der Beek, Bart, Greenberg, David, Dagan, Ron
Médium: Artigo
Jazyk:Inglês
Vydáno: Centers for Disease Control and Prevention 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7774550/
https://ncbi.nlm.nih.gov/pubmed/33350916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2701.201178
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky